| Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ... European urology 72 (4), 544-554, 2017 | 754 | 2017 |
| Active surveillance for prostate cancer: a systematic review of the literature MA Dall’Era, PC Albertsen, C Bangma, PR Carroll, HB Carter, ... European urology 62 (6), 976-983, 2012 | 718 | 2012 |
| Active surveillance for the management of prostate cancer in a contemporary cohort MA Dall'Era, BR Konety, JE Cowan, K Shinohara, F Stauf, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 463 | 2008 |
| Active surveillance for early‐stage prostate cancer: review of the current literature MA Dall'Era, MR Cooperberg, JM Chan, BJ Davies, PC Albertsen, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 373 | 2008 |
| Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer TJ Walsh, MA Dall’Era, MS Croughan, PR Carroll, PJ Turek The Journal of urology 178 (4), 1440-1446, 2007 | 323 | 2007 |
| Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer H Zargar, PN Espiritu, AS Fairey, LS Mertens, CP Dinney, MC Mir, ... European urology 67 (2), 241-249, 2015 | 298 | 2015 |
| Genomic markers in prostate cancer decision making V Cucchiara, MR Cooperberg, M Dall’Era, DW Lin, F Montorsi, ... European urology 73 (4), 572-582, 2018 | 257 | 2018 |
| Prostate cancer: the use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy JS Wolf Jr, M Cher, M Dall'Era, JC Presti Jr, H Hricak, PR Carroll The Journal of urology 153 (3), 993-999, 1995 | 257 | 1995 |
| Pathological outcomes of candidates for active surveillance of prostate cancer SL Conti, M Dall'Era, V Fradet, JE Cowan, J Simko, PR Carroll The Journal of urology 181 (4), 1628-1634, 2009 | 207 | 2009 |
| No improvement noted in overall or cause‐specific survival for men presenting with metastatic prostate cancer over a 20‐year period JN Wu, KM Fish, CP Evans, RW deVere White, MA Dall'Era Cancer 120 (6), 818-823, 2014 | 159 | 2014 |
| A multi-institutional analysis of outcomes of patients with clinically node positive urothelial bladder cancer treated with induction chemotherapy and radical cystectomy K Zargar-Shoshtari, H Zargar, Y Lotan, JB Shah, BW Van Rhijn, ... The Journal of urology 195 (1), 53-59, 2016 | 108 | 2016 |
| Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus D Tilki, HG Nguyen, MA Dall’Era, R Bertini, JA Carballido, T Chromecki, ... European urology 66 (3), 577-583, 2014 | 105 | 2014 |
| Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer MA Dall’Era, NB Hampson, RA Hsi, B Madsen, JM Corman The Journal of urology 176 (1), 87-90, 2006 | 103 | 2006 |
| Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer R Seiler, EA Gibb, NQ Wang, HZ Oo, HM Lam, KE Van Kessel, ... Clinical cancer research 25 (16), 5082-5093, 2019 | 96 | 2019 |
| Surgical management after active surveillance for low‐risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment MA Dall’Era, JE Cowan, J Simko, K Shinohara, B Davies, BR Konety, ... BJU international 107 (8), 1232-1237, 2011 | 93 | 2011 |
| Active surveillance for prostate cancer compared with immediate treatment: an economic analysis KA Keegan, MA Dall'Era, B Durbin‐Johnson, CP Evans Cancer 118 (14), 3512-3518, 2012 | 89 | 2012 |
| Neoadjuvant dose dense MVAC versus gemcitabine and cisplatin in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy H Zargar, JB Shah, BW van Rhijn, S Daneshmand, TJ Bivalacqua, ... The Journal of Urology 199 (6), 1452-1458, 2018 | 85 | 2018 |
| Molecular characterization of neuroendocrine-like bladder cancer J Batista da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ... Clinical cancer research 25 (13), 3908-3920, 2019 | 84 | 2019 |
| Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer C Liu, W Lou, JC Yang, L Liu, CM Armstrong, AP Lombard, R Zhao, ... Nature communications 9 (1), 4700, 2018 | 82 | 2018 |
| Final pathological stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer—does pT0 predict better survival than pTa/Tis/T1? H Zargar, K Zargar-Shoshtari, Y Lotan, JB Shah, BW van Rhijn, ... The Journal of Urology 195 (4 Part 1), 886-893, 2016 | 80 | 2016 |
